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n treatment-naïve and treatment-experienced patients.
rom these and other trials it was possible to conclude that
he use of these new agents in monotherapy, owing to its
elative low genetic barrier, was associated with a rapid
evelopment of resistance to the drugs and that the use
f ribavirin was always necessary. These new agents will be
vailable for general clinical use in the next years but they
ust be used as a complement of current therapy.
oi:10.1016/j.ijid.2010.02.1516
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anagement of HIV and Hepatitis C Co-infection
. Brito
University of Illinois, Chicago, IL, USA
The rate of coinfection of HIV with Hepatitis C is high
n countries where the mode of transmission is predomi-
antly intravenous drug abuse. The success of highly active
ntiretroviral therapy (HAART) in decreasing HIV related
orbidity and mortality has shifted the focus of care for
eople living with HIV. More attention is being paid to the
anagement and prevention of chronic ailments such as car-
iovascular, liver and renal disease. Thus, it is important
or the clinician treating HIV infected patients to recog-
ize the clinical presentations, spectrum of disease, efﬁcacy
f treatment and principles of management for coinfected
atients. Patients coinfected with the HIV and Hepatitis C
iruses have an increased risk of liver related morbidity and
more rapid progression to end-stage liver disease. The
reatment of these patients is complex owing to the signiﬁ-
ant side effects and limited efﬁcacy of Peg Interferon and
ibavirin. This lecture will review the epidemiology, nat-
ral history, diagnosis, management and newer treatment
odalities in HIV/HCV coinfection.
oi:10.1016/j.ijid.2010.02.1517
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nfectious diseases and infection control after natural dis-
sters
. Ambrosioni ∗, D. Lew, I. Uc¸kay
University Hospitals of Geneva, Geneva, Switzerland
Infections are frequent complications after natural
atastrophes. Previous reports suggest a high prevalence
f colonisation and infection with multi-resistant Gram-
egative pathogens in victims of natural disasters.
Literature regarding infections and infection control
easures after natural disasters was reviewed from 1986
hrough the end of 2009, with special emphasis on the 2004
sunami. Local microbiology of patients followed in our insti-
ution was also reviewed.Patients admitted after natural disasters often have
olymicrobial infections with atypical bacteria and fungi.
oreover, they are usually colonised or infected with
ulti-drug resistant organisms. These pathogens are
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cquired either nosocomially or environmentally. Sev-
ral studies have suggested that Gram-negative bacteria
re more prevalent than Gram-positive bacteria. A high
ncidence of colonisation and infection with extended
pectrum -lactamase-producing bacteria, multi-resistant
on-fermenting Gram-negative rods and difﬁcult to treat
ungal infections are found in these patients and may pose
hallenges in routine hospital care.
According to published date and our own experience,
e recommend pre-emptive contact isolation for victims
f natural disasters during hospitalisation until results of
icrobiological cultures become available. If respiratory
ymptoms are present, droplet isolation must be included.
hese measures should also be applied during the air
ransportation of these patients. Considering the differ-
nt multi-resistant colonisers, cohorting patients must be
voided whenever possible. In cases of life-threatening
nfections, empiric antibiotic therapy must cover multi-
esistant non-fermenting Gram-negative rods. Clinicians
ust be aware of unusual microbiological ﬁndings in these
atients.
oi:10.1016/j.ijid.2010.02.1518
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. Shibl
King Saud University, Ryadh, Saudi Arabia
Infectious diseases and war have been witnessed for as
ong as human life. Historically, infectious diseases have
een responsible for the majority of deaths during war;
owever, numerous medical and military advances have
eversed this trend, resulting in more deaths from bat-
le than infectious diseases in the 20th century. Wounds
ncurred in war are grossly contaminated with bacteria and
ost will become infected unless appropriate treatment is
nitiated quickly.Common infections include respiratory as
ell as gastrointestinal infections. Endemic diseases are also
eported during the war and they include Brucella, Q-fever,
alaria, Sandﬂy fever and Leishmaniasis. Non-battle injuries
uch as mental and combat stress are common; while battle
ssociated infections such as trauma- related complications
re extensively reported.
Multidrug resistances (MDR) Gram negative bacilli have
een reported in war wound infections, particularly Acine-
obacter spp, Enterobacter spp.and Pseudomonas spp. and
herefore empirical treatment for infected war wounds
hould be given to cover MDR. Other war related infec-
ions such as malaria, MDR tuberculosis, chronic Q fever and
rucellosis may become apparent after returning home and
herefore they should be considered due to their lengthy
eactivation periods. In addition to this, vaccines have
roven to be an important breakthrough to help prevent the
pread of several infectious diseases.
War wounds are predisposed to infection due to envi-
onmental conditions on the battleﬁeld, devitalized tissue,
nd foreign bodies in the wound as well as delays in
vacuating causalities. Knowledge of likely pathogens for
articular infections and sites, as well as optimal antibi-
tics to eradicate those pathogens will aid battleﬁeld
